Literature DB >> 12666301

[Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA). Spain].

C Saro Gismera1, S Riestra Menéndez, A Milla Crespo, R Sánchez Fernández, M Lacort Fernández, G Argüelles Fernández, Z Chovac, J I Florido Mancheño, J L Antón Magarzo, A Altadill Arregui, F Vizoso, E Pineda García, E Fernández de Ocariz Archs, J Albert Colomer, J García Pérez, L López Rivas, J L S Lombraña.   

Abstract

AIMS: To know and to compare Inflammatory Bowel Disease (IBD) Incidence and Prevalence rates in in five areas of Asturias (Spain). We conducted a prospective epidemiologic study of IBD in the Province of Liege (1 million inhabitants). PATIENT AND METHODS: We conducted a descriptive, populational, collaborative epidemiologic study, retrospective between 1954 and 1993 and prospective between 1994 and 1997. All patients diagnosed according to a standard protocol for case ascertainment and definition of IBD, aged 14 years or more are included, in five areas of Asturias (Spain) (461,965 inhabitants).
RESULTS: For the period 1954 to 1997, 1018 IBD have been diagnosed [565 ulcerative colitis (UC) (55.5%), 415 Crohn's disease (CD) (40.8%) and 38 undefined IBD (IC) (3.7%)]; [482 women (47.2%), 536 males (52.8%)]. In the 4 year-prospective period, 306 cases were collected: 176 UC (57.51%), 110 CD (35.94) and 20 IC (6.53%); UC/CD: 1.6. Without appreciable and significant differences between Frequency of illness groups and sexes. IBD incidence rate (per 100,000 per year) (1954-97) is 5.12 (95% CI = 3.05-7.18) (UC: 2.84; CD: 2.08; IC: 0.19; UC/CD 1.36). In the 4 years- prospective study, IBD incidence rate is 16.55 (95% CI = 12.84-20.25), (UC: 9.52; CD: 5.95; IC: 1.08; UC/CD: 1.6). IBD prevalence rate in 1997 is 205.21 (95% CI = 182.14-227.29), (UC: 109.96; CD: 87.45; IC: 7.79). Comparisons have settled down among the studied areas, without finding differences statistically significant.
CONCLUSIONS: Inflammatory Bowel Disease incidence and prevalence rates of in our region are homogeneous between the cities investigated and superior than those historically reported in Spanish studies. These results were similar to those observed in European studies.

Entities:  

Mesh:

Year:  2003        PMID: 12666301

Source DB:  PubMed          Journal:  An Med Interna        ISSN: 0212-7199


  5 in total

1.  IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study.

Authors:  Alexis Ramos; Xavier Calvet; Beatriz Sicilia; Mercedes Vergara; Ariadna Figuerola; Jaume Motos; Adoración Sastre; Albert Villoria; Fernando Gomollón
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

2.  The prevalences of some rheumatic diseases in western Turkey: Havsa study.

Authors:  Necati Cakır; Ömer Nuri Pamuk; Emine Derviş; Neşe Imeryüz; Haşim Uslu; Ömer Benian; Edip Elelçi; Genco Erdem; Fatma Oğuz Sarvan; Mustafa Senocak
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

Review 3.  Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?

Authors:  Ayesha Shah; Nicholas J Talley; Marjorie Walker; Natasha Koloski; Mark Morrison; Daniel Burger; Jane M Andrews; Michael McGuckin; Mike Jones; Gerald Holtmann
Journal:  Dig Dis Sci       Date:  2017-03-09       Impact factor: 3.199

4.  Determination of Anti-Anisakis Simplex Antibodies and Relationship with αβ and γδ Lymphocyte Subpopulations in Patients with Crohn's Disease.

Authors:  C Benet-Campos; C Cuéllar; C García-Ballesteros; V Zamora; R Gil-Borrás; I Catalán-Serra; F López-Chuliá; J C Andreu-Ballester
Journal:  Dig Dis Sci       Date:  2017-02-06       Impact factor: 3.199

5.  Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).

Authors:  Ignacio Marín-Jiménez; Cristina Saro; Verónica Díaz; Manuel Barreiro-de Acosta; María Gómez-García; Ana Gutiérrez Casbas
Journal:  Drugs Context       Date:  2018-03-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.